Literature DB >> 20733406

High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthood.

Yasotharan Paramesparan, Lucy J Garvey, Jane Ashby, Caroline J Foster, Sarah Fidler, Alan Winston.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20733406     DOI： 10.1097/QAI.0b013e3181d90e8c

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  25 in total

1.  Early viral suppression improves neurocognitive outcomes in HIV-infected children.

Authors:  Claudia S Crowell; Yanling Huo; Katherine Tassiopoulos; Kathleen M Malee; Ram Yogev; Rohan Hazra; Richard M Rutstein; Sharon L Nichols; Renee A Smith; Paige L Williams; James Oleske; William J Muller
Journal:  AIDS       Date:  2015-01-28       Impact factor: 4.177

2.  Neurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood.

Authors:  Luminita Ene; Donald R Franklin; Ruxandra Burlacu; Anca E Luca; Andreea G Blaglosov; Ronald J Ellis; Terry J Alexander; Anya Umlauf; Igor Grant; Dan C Duiculescu; Cristian L Achim; Thomas D Marcotte
Journal:  J Neurovirol       Date:  2014-09-04       Impact factor: 2.643

3.  Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

Review 4.  HIV-1 proteins, Tat and gp120, target the developing dopamine system.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

5.  Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

Authors:  Sylvia Fitting; Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2017-10-27       Impact factor: 2.457

Review 6.  Treatment of perinatal viral infections to improve neurologic outcomes.

Authors:  William J Muller
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

7.  S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV.

Authors:  Kristen A McLaurin; Hailong Li; Anna K Cook; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2020-09-01       Impact factor: 2.643

8.  Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.

Authors:  Landhing M Moran; Sylvia Fitting; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2014-10-05       Impact factor: 2.457

9.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

10.  Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related Factors.

Authors:  Ali Judd; Marthe Le Prevost; Diane Melvin; Alejandro Arenas-Pinto; Francesca Parrott; Alan Winston; Caroline Foster; Kate Sturgeon; Katie Rowson; Di M Gibb
Journal:  Clin Infect Dis       Date:  2016-08-31       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.